• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Danielle Kirkman: Recent Findings on Exercise and Hypertension in Patients With Kidney Disease

Video

Recent findings have shown that aerobic exercise improves microvascular function and coronary artery function in patients with kidney disease, but further research is needed on the relationship between exercise and kidney function, said Danielle Kirkman, PhD, assistant professor at Virginia Commonwealth University.

Recent findings have shown that aerobic exercise improves microvascular function and coronary artery function in patients with kidney disease, but further research is needed on the relationship between exercise and kidney function, said Danielle Kirkman, PhD, assistant professor at Virginia Commonwealth University.

Transcript

What are some recent findings about the role of exercise in hypertension and kidney disease?

Some recent findings from our group at University of Delaware where I studied my postdoc, we recently found that aerobic exercise in nondialysis kidney disease patients significantly improved microvascular function and coronary artery function, so these are both implicated in the development of hypertension, so certainly this could be playing a role in lowering blood pressure. Previous studies before ours have shown that specifically in the non—kidney disease population, aerobic exercise reduces blood pressure by about 4 to 5 mm Hg. Certainly there’s a lot more research to be done in this field; I think we need some larger multicenter trials looking at the effects of exercise in lowering blood pressure.

With regards to kidney function, I think this is an area that’s still pretty underinvestigated, and it’s really a hot topic for those involved with exercise and chronic kidney disease. We are still trying to figure out whether exercise reduces the progression of kidney disease, whether it improves kidney function and improves perfusion to the kidney.

Related Videos
Shawn Kwatra, MD, dermatologist, John Hopkins University
Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients with Plaque Psoriasis
dr krystyn van vliet
Martin Dahl, PhD, senior vice president, AnaptysBio
Jeff Stark, MD, vice president, head of medical immunology, UCB.
Jonathan Silverberg, MD, PhD, MPH, FAAD, professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences
Monica Li, MD, University of British Columbia
Robert Sidbury, MD, MPH, FAAD, professor of pediatrics, division head of dermatology, Seattle Children's Hospital, University of Washington School of Medicine
Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University Chicago Medical School, founder and director of the Center for Medical Dermatology and Immunology Research
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.